No Access
INSIDE INDUSTRY
https://doi.org/10.1142/S021903031500066XCited by:0 (Source: Crossref)
Abstract
Jardiance® is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial
Gencia and Takeda Team to Discover and Develop Novel Class of Mitochondrial Therapeutics
Practo acquires Insta Health for US$12M
Merck Launches Partnership with Department of Health and Philippine Thyroid Association
Apps and wearables across applications will be enabled with the IoT
Evidera Announces Evalytica™, Next-Generation, Cloud-Based Software for Fast, Transparent Analysis of Healthcare Data
ICON and IBM to Revolutionise Clinical Trial Feasibility, Patient Recruitment and Study Start-up Timelines
Keywords:
